XML 39 R23.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Significant Accounting Policies (Tables)
 3 Months Ended
Mar. 31, 2024
Accounting Policies [Abstract]  
Schedule of reconciliation of cash and cash equivalents
The following is a reconciliation of cash and cash equivalents on the unaudited condensed consolidated balance sheets to total cash, cash equivalents and restricted cash on the unaudited condensed consolidated statements of cash flows:
In millionsMarch 31,
2024		December 31,
2023
Cash and cash equivalents$9,801 $8,196 
Restricted cash (included in other current assets)51 90 
Restricted cash (included in other assets)255 239 
Total cash, cash equivalents and restricted cash in the statements of cash flows$10,107 $8,525 
Schedule of accounts receivable, net Accounts receivable, net at March 31, 2024 and December 31, 2023 was composed of the following:
In millionsMarch 31,
2024		December 31,
2023
Trade receivables$10,586 $11,908 
Vendor and manufacturer receivables12,681 15,711 
Premium receivables5,420 3,714 
Other receivables3,530 3,894 
   Total accounts receivable, net$32,217 $35,227 
Roll forward of deferred acquisition costs
The following is a roll forward of deferred acquisition costs for the three months ended March 31, 2024 and 2023:
Three Months Ended
March 31,
In millions20242023
Deferred acquisition costs, beginning of the period$1,502$1,219
Capitalizations134135
Amortization expense(76)(64)
Deferred acquisition costs, end of the period$1,560$1,290
Schedule of disaggregation of revenue
The following table disaggregates the Company’s revenue by major source in each segment for the three months ended March 31, 2024 and 2023:
In millionsHealth Care
Benefits		Health
Services		Pharmacy &
Consumer
Wellness 		Corporate/
Other		Intersegment
Eliminations		Consolidated
Totals
Three Months Ended March 31, 2024
Major goods/services lines:
Pharmacy$— $37,726 $22,784 $— $(12,113)$48,397 
Front Store— — 5,370 — — 5,370 
Premiums30,379 — — 12 — 30,391 
Net investment income353 — — 101 — 454 
Other1,504 2,559 571 2 (811)3,825 
Total$32,236 $40,285 $28,725 $115 $(12,924)$88,437 
Health Services distribution channel:
Pharmacy network (1)
$20,464 
Mail & specialty (2)
17,262 
Other2,559 
Total$40,285 
Three Months Ended March 31, 2023
Major goods/services lines:
Pharmacy$— $43,737 $21,780 $— $(12,732)$52,785 
Front Store— — 5,597 — — 5,597 
Premiums24,339 — — 13 — 24,352 
Net investment income (loss)164 — (3)173 — 334 
Other1,374 854 548 2 (568)2,210 
Total$25,877 $44,591 $27,922 $188 $(13,300)$85,278 
Health Services distribution channel:
Pharmacy network (1)
$27,592 
Mail & specialty (2)
16,145 
Other854 
Total$44,591 

_____________________________________________
(1)Health Services pharmacy network is defined as claims filled at retail and specialty retail pharmacies, including the Company’s retail pharmacies and LTC pharmacies, as well as activity associated with Maintenance Choice®, which permits eligible client plan members to fill their maintenance prescriptions through mail order delivery or at a CVS pharmacy retail store for the same price as mail order.
(2)Health Services mail & specialty is defined as specialty mail claims inclusive of Specialty Connect® claims picked up at a retail pharmacy, as well as mail order and specialty claims fulfilled by the Pharmacy & Consumer Wellness segment.
Schedule of receivables and contract liabilities from contracts with customers
The following table provides information about receivables and contract liabilities from contracts with customers:
In millionsMarch 31,
2024		December 31,
2023
Trade receivables (included in accounts receivable, net)$10,586 $11,908 
Contract liabilities (included in accrued expenses)117 149